Source: Getty Imagesvaccine may increase the risk of developing a neurological condition known as Guillain-Barré syndrome (GBS). In some cases, GBS can develop into full "locked-in syndrome" in which the patient remains fully conscious but cannot move any part of their body. Between January to October 2021, 996 GBS cases were recorded in the UK National Immunoglobulin Database, but there was an unusual spike in GBS reports occurring between March and April 2021. Analysis showed 198 GBS cases (20 per cent) occurred within six weeks of the first-dose Covid-19 vaccination in England. Overall, following the first dose of the AstraZeneca vaccine, there were 5.8 excess GBS cases % million doses of vaccine, equating to an absolute total excess between January-July 2021 of between 98-140 cases.

Source: Daily Nation May 29, 2022 19:40 UTC